Current Trends in Pharmacotherapy: BCPS Spring Webinar
ACPE Numbers: 0204-0000-26-905-H01-P
Content Release Date: March 25, 2026 - available for pre-sale
Expiration Dates: March 23, 2027
Activity Type: Application-based
CE Credits: 1 contact hour (BPS and ACPE)
Activity Fee: $25 (ASHP member); $35 (non-member)
Activity Overview
Expert-led discussions explore emerging topics and evolving practices in pharmacotherapy, supporting BCPS recertification and real-world clinical decision-making. This activity may be used to meet the BPS requirement for board-certified pharmacists to work towards completing two hours of recertification credit annually.
Highlights key updates in the 2025 AHA/ACC Hypertension Guidelines, including revised treatment thresholds and recommendations for special populations, with patient cases demonstrating how to apply these changes to initiate and adjust therapy.
Members and nonmembers may register to attend the live webinar at no cost and claim ACPE credit. Learners seeking to earn board recertification credit must purchase the online webinar individually or as part of a discounted package; member and nonmember pricing applies.
This activity is part of the ASHP professional development program for BCPS recertification approved by BPS.
Accreditation
Target Audience
This recertification activity is intended for board certified pharmacists seeking to update their knowledge and skills in pharmacotherapy.
Recertification Credit
Board certified pharmacists are eligible to receive up to 1 contact hour of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.
This course is not intended for those preparing to take the BPS Compounded Sterile Preparations Pharmacy Specialty Examination for Certification.
ASHP is approved by BPS as a provider for the recertification of BCPS.
|
Learning Activity |
ACPE Number |
Contact Hours |
|
Current Trends in Pharmacotherapy: BCPS Spring Webinar - Hypertension Guideline Updates |
0204-0000-26-905-H01-P |
1 ACPE |
|
→ Recertification Assessment (TBD% passing score required) |
1 BPS |
|
Learning Objectives
Current Trends in Pharmacotherapy: BCPS Spring Webinar - Hypertension Guideline Updates
ACPE #: 0204-0000-26-905-H01-P
- Summarize key changes to the 2025 AHA/ACC Hypertension Guidelines.
- Design an optimal initial antihypertensive regimen for a patient with newly diagnosed hypertension by analyzing their comorbidities, baseline BP, and adherence potential.
- Modify an antihypertensive regimen for further blood pressure reduction or mitigate adverse drug events from first line therapies.
This activity is approved for Board-Certified Pharmacotherapy Specialist (BCPS) recertification credit.
Faculty
Christopher Betz, PharmD, BCPS, FASHP, FKSHP*
Clinical Pharmacist Practitioner – Cardiology/Pharmacogenomics, Robley Rex VA Medical Center
Adjunct Professor, Sullivan University College of Pharmacy & Health Sciences
Clinical Assistant Professor of Medicine, University of Louisville School of Medicine
Snehal H. Bhatt, PharmD, BCPS, FASHP, AACC*
Professor of Pharmacy Practice, MCPHS
Clinical Pharmacist, Beth Israel Deaconess Medical Center
*Content matter expert
Reviewers
Sue Dombrowski, MS, RPh
Field Testers
TBD
Relevant Financial Relationship Disclosures
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.
All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.
All other planners, presenters, reviewers, ASHP staff and others with an opportunity to control content report no financial relationships relevant to this activity.
Methods and CE Requirements
Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:
- Complete the attestation statement
- Review all content
- Complete and pass the assessment
- Complete the evaluations
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
Development
These activities were developed by ASHP.